{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiahpids27gifxm6jrzwlcrr7zgbvgjpyegzpvnrzxnk6ki3e2ikym",
    "uri": "at://did:plc:ycan73jxazji4jml4x3432hf/app.bsky.feed.post/3mnvk3jjocdy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreici37yjme7pdiihgeo555rqwgengxuchgpvzuvqt3br7hwxvslyqi"
    },
    "mimeType": "image/jpeg",
    "size": 13049
  },
  "path": "/gsk-acquires-nuvalent-oncology-pipeline/",
  "publishedAt": "2026-06-10T01:06:25.000Z",
  "site": "https://cryptobriefing.com",
  "tags": [
    "News",
    "GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business",
    "Crypto Briefing"
  ],
  "textContent": "GSK's acquisition of Nuvalent signals a strategic pivot towards oncology, potentially reshaping its market position and investor dynamics.\n\nThe post GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business appeared first on Crypto Briefing.",
  "title": "GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business"
}